1
/
of
1
Elabscience
SKU:PKSH032630
Recombinant Human Interleukin-20/IL-20 Protein
Recombinant Human Interleukin-20/IL-20 Protein
Regular price
$178.00 USD
Regular price
Sale price
$178.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Interleukin-20/IL-20 Protein, a cutting-edge biotechnological advancement in the field of protein therapeutics. This meticulously engineered protein is derived from human sources, ensuring utmost compatibility and efficacy in various therapeutic applications.
The Recombinant Human Interleukin-20/IL-20 Protein exhibits remarkable potential in modulating immune responses and regulating inflammatory processes. Its unique ability to interact with specific receptors on target cells enables precise and targeted intervention, making it an invaluable tool in the treatment of various immunological disorders.
With its exceptional purity and stability, this protein is manufactured using state-of-the-art recombinant DNA technology, guaranteeing a consistent and reliable product. Rigorous quality control measures are implemented throughout the production process to ensure the utmost safety and efficacy of the Recombinant Human Interleukin-20/IL-20 Protein.
This groundbreaking therapeutic protein holds immense promise in the fields of dermatology, rheumatology, and oncology, among others. Its potential applications include the treatment of psoriasis, rheumatoid arthritis, and certain types of cancer, where it can effectively modulate immune responses and mitigate inflammatory processes.
The Recombinant Human Interleukin-20/IL-20 Protein is supplied in a convenient lyophilized form, allowing for easy reconstitution and administration. Its exceptional stability ensures a prolonged shelf life, facilitating storage and transportation without compromising its therapeutic potency.
In conclusion, the Recombinant Human Interleukin-20/IL-20 Protein represents a groundbreaking advancement in protein therapeutics, offering a highly targeted and effective approach to modulating immune responses and regulating inflammatory processes. With its exceptional purity, stability, and potential applications in various therapeutic fields, this protein holds immense promise in revolutionizing the treatment of immunological disorders.
The Recombinant Human Interleukin-20/IL-20 Protein exhibits remarkable potential in modulating immune responses and regulating inflammatory processes. Its unique ability to interact with specific receptors on target cells enables precise and targeted intervention, making it an invaluable tool in the treatment of various immunological disorders.
With its exceptional purity and stability, this protein is manufactured using state-of-the-art recombinant DNA technology, guaranteeing a consistent and reliable product. Rigorous quality control measures are implemented throughout the production process to ensure the utmost safety and efficacy of the Recombinant Human Interleukin-20/IL-20 Protein.
This groundbreaking therapeutic protein holds immense promise in the fields of dermatology, rheumatology, and oncology, among others. Its potential applications include the treatment of psoriasis, rheumatoid arthritis, and certain types of cancer, where it can effectively modulate immune responses and mitigate inflammatory processes.
The Recombinant Human Interleukin-20/IL-20 Protein is supplied in a convenient lyophilized form, allowing for easy reconstitution and administration. Its exceptional stability ensures a prolonged shelf life, facilitating storage and transportation without compromising its therapeutic potency.
In conclusion, the Recombinant Human Interleukin-20/IL-20 Protein represents a groundbreaking advancement in protein therapeutics, offering a highly targeted and effective approach to modulating immune responses and regulating inflammatory processes. With its exceptional purity, stability, and potential applications in various therapeutic fields, this protein holds immense promise in revolutionizing the treatment of immunological disorders.
Share
